Lapatinib New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
Publications Citing of Biochempartner's Lapatinib
| CAS No. | 231277-92-2 | Cat. No. | BCP01874 |
| Related Products | 388082-78-8（Lapatinib Ditosylate） 388082-77-7（Lapatinib ditosylate） | ||
| Name | Lapatinib | ||
| Synonyms | GSK572016; GSK-572016; GSK 572016; GW2016; GW-2016; GW 2016; | ||
| SMILES | O=S(CCNCC1=CC=C(C2=CC3=C(NC4=CC=C(OCC5=CC=CC(F)=C5)C(Cl)=C4)N=CN=C3C=C2)O1)(C)=O | ||
| Chemical Name | |||
| Formula | C29H26ClFN4O4S | M. Wt | 581.06 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Lapatinib weakly inhibits the activity of ErbB4 with IC50 of 367 nM, and displays >300-fold selectivity for EGFR and ErbB2 over other kinases such as c-Src, c-Raf, MEK, ERK, c-Fms, CDK1, CDK2, p38, Tie-2, and VEGFR2. Lapatinib significantly inhibits receptor autophosphorylation of EGFR and ErbB2 in a dose-dependent manner with IC50 of 170 nM and 80 nM, respectively in HN5 cells; as well as 210 nM and 60 nM, respectively in BT474 cells. Unlike OSI-774 and Iressa (ZD1839) which preferentially inhibit the growth of the EGFR-overexpressing cells, Lapatinib inhibits the growth of both EGFR- and ErbB2-overexpressing cells. | ||
Recommend Products
More >
-
Mobocertinib succinate
Cat. No.：BCP33315
No.：2389149-74-8
Product Details -
Mobocertinib
Cat. No.：BCP31045
No.：1847461-43-1
Product Details -
Pyrotinib dimaleate
Cat. No.：BCP29462
No.：1397922-61-0
Product Details -
Pyrotinib
Cat. No.：BCP29458
No.：1269662-73-8
Product Details -
-
-
BMS-599626
Cat. No.：BCP19580
No.：714971-09-2
Product Details -
AZD-8931 Difumaric acid
Cat. No.：BCP24789
No.：1196531-39-1
Product Details -
Pertuzumab
Cat. No.：BCP18201
No.：380610-27-5
Product Details -
AV-412 Tosylate
Cat. No.：BCP23783
No.：451493-31-5
Product Details -
Canertinib dihydrochloride
Cat. No.：BCP01902
No.：289499-45-2
Product Details -
-
Afatinib(cis-trans isomerismtautomers)
Cat. No.：BCP01779
No.：439081-18-2
Product Details -
-
BMS-599626 HCl
Cat. No.：BCP01780
No.：873837-23-1
Product Details -
-
Mubritinib
Cat. No.：BCP02837
No.：366017-09-6
Product Details -
-
Trastuzumab
Cat. No.：BCP05130
No.：180288-69-1
Product Details -
Tyrphostin AG 879
Cat. No.：BCP08354
No.：148741-30-4
Product Details
Tags:Lapatinib supplier,Lapatinib purchase,Lapatinib manufacturer,Lapatinib distributor,Lapatinib cost,Lapatinib buy,Lapatinib for sale